本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。化腐朽为神奇的疗效,让CAR-T成为最受期待的抗癌疗法之一;但百万级的价格,致使CAR-T疗法的商业化并没有达到预期中的高度。显而易见,如何有效降低CAR-T疗法的成本,正是决定CAR-T疗法全面商业化爆发的关键。纵观已经上市的CAR-T疗法,之所以成本居高不下,核心原因在于千人千样的“定制化”属性。CAR-T疗法需要采集每一位患者...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.